Principal Financial Group Inc Seelos Therapeutics, Inc. Transaction History

Principal Financial Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.51 - $0.93 $15,245 - $27,801	-29,894 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$0.84 - $1.71 $514 - $1,046	612 Added 2.09%	29,894 $25,000
Q4 2021 Feb 09, 2022	SELL	$1.59 - $2.38 $10,762 - $16,110	-6,769 Reduced 18.78%	29,282 $48,000
Q3 2021 Nov 09, 2021	BUY	$1.69 - $2.89 $10,236 - $17,504	6,057 Added 20.19%	36,051 $87,000
Q2 2021 Aug 10, 2021	BUY	$2.64 - $6.32 $79,184 - $189,562	29,994 New	29,994 $79,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $109M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.